Phibro Animal Health | PAHC - Operating Profit

Stock Price
52.26
Daily Change
0.99 1.93%
Monthly
31.08%
Yearly
102.79%
Q1 Forecast
12.72

Phibro Animal Health reported $25.53M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Align Technology USD 224.71M 40.06M Dec/2025
ANI Pharmaceuticals USD 22.83M 7.66M Sep/2025
Assertio Holdings USD -3.05M 569K Sep/2024
Aurora Cannabis CAD -55.67M 35.45M Sep/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Canopy Growth CAD -14.3M 3.18M Sep/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Henry Schein USD 198M 22M Sep/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Merck USD 6.24B 318M Dec/2025
Nektar Therapeutics USD -34.34M 15.43M Sep/2024
Pacira USD 13.15M 2.92M Sep/2025
Phibro Animal Health USD 25.53M 7.83M Dec/2024
Prestige Brands USD 82.49M 2.82M Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.32M Sep/2025
Zoetis USD 835M 101M Dec/2025